Terms: = Germ cell tumor AND STIL, SIL, 6491, ENSG00000123473, Q15468
87 results:
1. Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.
Bai X; Attrill GH; Gide TN; Ferguson PM; Nahar KJ; Shang P; Vergara IA; Palendira U; da Silva IP; Carlino MS; Menzies AM; Long GV; Scolyer RA; Wilmott JS; Quek C
Nat Commun; 2024 Apr; 15(1):3014. PubMed ID: 38589406
[TBL] [Abstract] [Full Text] [Related]
2. The roles of different forms of IL-15 in human melanoma progression.
Di Matteo S; Munari E; Fiore PF; Santopolo S; Sampaoli C; Pelosi A; Chouaib S; Tumino N; Vacca P; Mariotti FR; Ebert S; Machwirth M; Haas D; Pezzullo M; Pietra G; Grottoli M; Buart S; Mortier E; Maggi E; Moretta L; Caruana I; Azzarone B
Front Immunol; 2023; 14():1183668. PubMed ID: 37334356
[TBL] [Abstract] [Full Text] [Related]
3. Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Rubatto M; Fava P; Stanganelli I; Ribero S; Pigozzo J; Di Giacomo AM; Ridolfi L; Tronconi MC; Trojaniello C; Bersanelli M; Garutti M; Indini A; De Risi I; De Tursi M; Merelli B; Morgese F; Occelli M; Cappellini GCA; Poletto S; Fedele D; Brugnara S; Frisinghelli M; Formisano L; Conca R; Tucci M; Russillo M; Ceroni L; Queirolo P; Targato G; Strippoli S; Mandalà M; Guida M; Quaglino P
Eur J Cancer; 2023 Jul; 187():25-35. PubMed ID: 37099946
[TBL] [Abstract] [Full Text] [Related]
4. [Successful Postoperative Recurrence Treatment of Malignant Melanoma of the Esophagus by Anti-PD-1 and Anti-CTLA-4 Combined Therapy-A Case Report].
Minagawa Y; Tanaka Y; Funatsuya T; Takahashi M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1160-1162. PubMed ID: 36281619
[TBL] [Abstract] [Full Text] [Related]
5. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells.
Zhai K; Huang Z; Huang Q; Tao W; Fang X; Zhang A; Li X; Stark GR; Hamilton TA; Bao S
Nat Cancer; 2021 Nov; 2(11):1136-1151. PubMed ID: 35122055
[TBL] [Abstract] [Full Text] [Related]
7. Pre-diagnostic levels of sVEGFR2, sTNFR2, sil-2Rα and sil-6R are associated with glioma risk: A nested case-control study of repeated samples.
Wu WY; Späth F; Wibom C; Björkblom B; Dahlin AM; Melin B
Cancer Med; 2022 Feb; 11(4):1016-1025. PubMed ID: 35029050
[TBL] [Abstract] [Full Text] [Related]
8. [Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].
Oya S; Yamasaki Y; Nakamura T; Morishige S; Yamaguchi M; Aoyama K; Seki R; Mouri H; Osaki K; Naito Y; Oshima K; Nagafuji K
Rinsho Ketsueki; 2020; 61(11):1605-1610. PubMed ID: 33298654
[TBL] [Abstract] [Full Text] [Related]
9. Differentiation of tumorigenic C6 Glioma cells Induced by Enhanced IL-6 Signaling.
Chu IR; Pan RL; Yang CS
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33227992
[No Abstract] [Full Text] [Related]
10. Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-tumor M1 Macrophages.
Park SM; Do-Thi VA; Lee JO; Lee H; Kim YS
Mol Cells; 2020 May; 43(5):479-490. PubMed ID: 32326670
[TBL] [Abstract] [Full Text] [Related]
11. [Metachronous Development of Mantle cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular Cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
12. Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay.
Banach P; Dereziński P; Matysiak J; Horała A; Swiatly A; Jasiński P; Kokot ZJ; Nowak-Markwitz E
Life Sci; 2018 Oct; 211():25-30. PubMed ID: 30195618
[TBL] [Abstract] [Full Text] [Related]
13. Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.
El Amrani M; Szanto CL; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
Anal Bioanal Chem; 2018 Sep; 410(23):5849-5858. PubMed ID: 29938370
[TBL] [Abstract] [Full Text] [Related]
14. Inflammatory response and treatment tolerance of long-term infusion of the anti-GD
Ceylan K; Jahns LJ; Lode BN; Ehlert K; Kietz S; Troschke-Meurer S; Siebert N; Lode HN
Pediatr Blood Cancer; 2018 Jun; 65(6):e26967. PubMed ID: 29350486
[TBL] [Abstract] [Full Text] [Related]
15. Research of differential expression of sil1RAP in low-grade gliomas between children and adults.
He J; Li X; Zhu W; Yu Y; Gong J
Brain Tumor Pathol; 2018 Jan; 35(1):19-28. PubMed ID: 29238884
[TBL] [Abstract] [Full Text] [Related]
16. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
17. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract] [Full Text] [Related]
18. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
[TBL] [Abstract] [Full Text] [Related]
19. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract] [Full Text] [Related]
20. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Chakrabarti M; Ray SK
Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
[TBL] [Abstract] [Full Text] [Related]
[Next]
